Press "Enter" to skip to content

Anti-hypertensive Drugs Market 2019 – Outlook by Growth Rate, Industry Size, Share, Top Key Players, and Development Factors Forecast to 2024

Anti-hypertensive Drugs

The “Anti-hypertensive Drugs Market” report 2019 provides a comprehensive analysis of Anti-hypertensive Drugs industry by types, applications, key players and regions. It shows the Anti-hypertensive Drugs market 2019-2024 by production, consumption, supply, gross margin, the revenue of the industry. Additionally, the Anti-hypertensive Drugs market report covers the details of market size, share, and growth rate of the market with respect to regions.

Get a Sample Copy of the Report At – https://www.industryresearch.co/enquiry/request-sample/14099123

Competitor Analysis:

Anti-hypertensive Drugs market includes the following leading manufacturers on the basis of sales, revenue, price, and gross margin.

  • Astrazeneca PLC
  • Boehringer Ingelheim
  • Daiichi Sankyo Company Limited
  • Johnson & Johnson Ltd
  • Lupin Limited
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Sanofi SA

    Market Overview:

  • The anti-hypertensive drugs market is expected to witness a CAGR of 4.5%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of hypertension, growing initiatives by private and government organizations, and rising awareness about hypertension.
  • The prevalence of hypertension has observed a significant rise over the past few years. Generally, blood pressure rises and falls throughout the day. However, it can damage one’s heart and result in health problems, if it stays high for a long time. High blood pressure is called hypertension. High blood pressure is the most harmful factor when it comes to the risk of heart disease and stroke, which is the leading cause of death in the United States. According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of people with high blood pressure have their condition under control. High blood pressure was a primary and contributing cause of death for more than 410,000 American citizens, in 2014. CDC also states that high blood pressure costs the nation USD 48.6 billion every year. This total includes the medications to treat high blood pressure, cost of health care services, and missed days of work.
  • However, even though most blood pressure medicines are easy to administrate, almost all medicines show certain side effects. Some common side effects of the antihypertensive medicines include cough, diarrhea or constipation, dizziness or lightheadedness, erection problems, feeling nervous, feeling tired, weak, drowsy, or a lack of energy, headache, skin rash, nausea or vomiting, and weight loss or gain without trying. These various side effects associated with the antihypertensive drugs are expected to hinder the growth of the market, over the forecast period.

    Anti-hypertensive Drugs market report presents in-depth analysis regarding the development, current trends, industry policies and regulations implemented in each of the geographical region. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Anti-hypertensive Drugs market report provides in-depth insight of Anti-hypertensive Drugs industry during 2019-2024.

    Scope of the Report:

  • Antihypertensive drugs are referred to as a class of drugs that are used in treating hypertension (high blood pressure). There are many classes of antihypertensive drugs, which have the ability to lower blood pressure by different means, and thus, prevent the complications associated with high blood pressure, including stroke and myocardial infarction.

    Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099123

    Key Market Trends:

    Diuretics is Expected to Hold a Significant Market Share in the Therapeutic Class

    Thiazide diuretics are the cornerstone of treatment for hypertension in most patients. Hydrochlorothiazide is the most commonly used thiazide diuretic in the United States. The Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure recommends thiazide-type diuretics to be one of the preferred drug treatments for hypertension, whether used on its own or along with other antihypertensive drugs, such as calcium channel blockers. Moreover, it was also noted that more than one-third of the adults affected by hypertension were reported to take diuretics.

    North America Dominates the Market and is Expected to do Same during the Forecast Period

    According to the AHA (American heart association), 74.9% of hypertension patients are currently undergoing treatment, and only 52.2% of patients have it under control. AHA projection shows that by 2030, about 41.4% of adults in the United States are expected to have hypertension. The demand for prompt and accurate diagnosis, and treatment of hypertension, identifying people predisposed to the disease, presence of technically advanced healthcare infrastructure, and management of the prognosis of the disease are some of the key market drivers of the North American anti-hypertension market.

    Reasons to Buy Anti-hypertensive Drugs Market Report:

    • Analysis of Anti-hypertensive Drugs market including revenues, future growth, market outlook
    • Historical data and forecast of Anti-hypertensive Drugs industry
    • Anti-hypertensive Drugs market report covers regional analysis including growth estimates
    • To analyze the end user markets including growth estimates
    • Profiles on laboratory balance including products, sales/revenues, and market position
    • Includes Anti-hypertensive Drugs market structure, market drivers, opportunities, and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) – https://www.industryresearch.co/purchase/14099123

    Anti-hypertensive Drugs Market Report Covers the Following Questions:

    • What trends, challenges and barriers are influencing its growth?
    • What is the and regional outlook for Anti-hypertensive Drugs market?
    • Who are the key players, and what are their strategies?
    • What is the status of Anti-hypertensive Drugs status worldwide?
    • What are the Anti-hypertensive Drugs market challenges to market growth? 
    • What are the Anti-hypertensive Drugs market challenges to market growth? 
    • What are the types and applications of Anti-hypertensive Drugs?
    • What is the market share of each type and application? 

    Detailed TOC of Anti-hypertensive Drugs Market 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Hypertension
    4.2.2 Growing Initiatives by Private and Government Organizations
    4.2.3 Rising Awareness about Hypertension
    4.3 Market Restraints
    4.3.1 Multiple Major Drug Patent Expiration
    4.3.2 Side-effects of Treatment Options
    4.3.3 Rise in Non-pharmacological Therapy
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Therapeutic Class
    5.1.1 Diuretics
    5.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors
    5.1.3 Angiotensin Receptor Blockers (ARBs)
    5.1.4 Beta Blockers
    5.1.5 Alpha Blockers
    5.1.6 Renin Inhibitors
    5.1.7 Calcium Channel Blockers
    5.1.8 Other Therapeutic Classes
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 United Kingdom
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Astrazeneca PLC
    6.1.2 Boehringer Ingelheim
    6.1.3 Daiichi Sankyo Company Limited
    6.1.4 Johnson & Johnson Ltd
    6.1.5 Lupin Limited
    6.1.6 Merck & Co. Inc.
    6.1.7 Novartis AG
    6.1.8 Pfizer Inc.
    6.1.9 Ranbaxy Laboratories Limited
    6.1.10 Sanofi SA

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Centrifugal Compressor Market 2019 | Market Research by Latest Business Opportunities, Industry Share, Top Manufacturer, and Global Market Insight Forecast to 2024

    Estimated Market Size and Share of Wooden Decking Market 2019 –Market Size, Share, CAGR%, Production, Consumption, Key Players, Future Demand, and Forecast till 2024

    Global Joint Replacement Market 2019 Leading Company Analysis by Size, Share, Types, Applications, Growing Demand Status, Recent Technologies, Forecast to 2024

    Global Regenerative Medicine Market 2019 Leading Company Analysis by Size, Share, Types, Applications, Growing Demand Status, Recent Technologies, Forecast to 2024